Tolerance and efficacy of rituximab in primary Sjögren syndrome (TEARS): results of the randomized controlled trial. - Université de Bretagne Occidentale Access content directly
Conference Papers Year : 2012

Tolerance and efficacy of rituximab in primary Sjögren syndrome (TEARS): results of the randomized controlled trial.

Xavier Mariette
Sandrine Jousse-Joulin
Eric Hachulla
Xavier Puechal
Jacques-Eric Gottenberg
  • Function : Author
  • PersonId : 918447
Vincent Goëb
Gilles Hayem
  • Function : Author
  • PersonId : 926013
Jacques Morel
Jacques-Olivier Pers

Domains

Immunology
No file

Dates and versions

hal-00783135 , version 1 (31-01-2013)

Identifiers

  • HAL Id : hal-00783135 , version 1

Cite

Valérie Devauchelle-Pensec, Xavier Mariette, Sandrine Jousse-Joulin, Jean-Marie Berthelot, Aleth Perdriger, et al.. Tolerance and efficacy of rituximab in primary Sjögren syndrome (TEARS): results of the randomized controlled trial.. Congrès de l'EULAR,"The European League against Rheumatism Congress", Jun 2012, Berlin, Germany. pp.75. ⟨hal-00783135⟩
226 View
0 Download

Share

Gmail Mastodon Facebook X LinkedIn More